Dbv Technologies
Clinical trials sponsored by Dbv Technologies, explained in plain language.
-
Life-Saving peanut patch offered to kids after trial ends
Disease control AVAILABLEThis program provides continued access to the Viaskin® peanut allergy patch for children who completed previous DBV clinical trials. It allows participants to keep receiving the skin patch treatment that helps reduce sensitivity to peanuts. The program continues until the patch b…
Sponsor: DBV Technologies • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Tiny patch, big hope: testing a peanut allergy treatment for toddlers
Disease control Recruiting nowThis study is testing the safety of a skin patch designed to help young children with peanut allergy. The patch contains a tiny amount of peanut protein and is worn on the back. The goal is to see if this treatment can help the body become less reactive to peanuts over time, pote…
Phase: PHASE3 • Sponsor: DBV Technologies • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC